1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING PREVALENCE OF METABOLIC DISORDERS
6.1.2 HIGH SPENDING ON HEALTHCARE
6.1.3 RISE OF MIDDLE-CLASS IN EMERGING ECONOMIES
6.2 MARKET RESTRAINTS
6.2.1 UNWILLINGNESS OF HOSPITALS AND IN-HOUSE PHARMACIES/DISPENCARIES TO MAINTAIN THE REQUIRED STOCK OF CLINICAL NUTRITION PRODUCTS
6.2.2 HETEROGENOUS NATURE OF GOVERNMENT COVERAGE/REIMBURSEMENT ACROSS COUNTRIES
6.2.3 IMPRECISE PERCEPTION ABOUT CLINICAL NUTRITION
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 SEGMENTATION-BY ROUTE OF ADMINISTRATION
7.1.1 ORAL
7.1.2 ENTERAL
7.1.3 PARENTERAL
7.2 SEGMENTATION-BY DISEASE TYPE
7.2.1 NUTRITIONAL SUPPORT IN CANCER
7.2.2 NUTRITIONAL SUPPORT IN GASTROINTESTINAL (GI) DISEASES
7.2.3 NUTRITIONAL SUPPORT IN NEUROLOGICAL DISEASES
7.2.4 NUTRITIONAL SUPPORT IN RENAL DISEASES
7.2.5 NUTRITIONAL SUPPORT IN RESPIRATORY DISEASES
7.2.6 NUTRITIONAL SUPPORT IN METABOLIC SYNDROMES
7.2.7 NUTRITIONAL SUPPORT IN OTHER DISEASE AREAS
7.3 SEGMENTATION-BY END USER
7.3.1 INFANT
7.3.2 CHILD
7.3.3 ADULT
7.3.4 GERIATRIC
7.4 SEGMENTATION-BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 UNITED STATES
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 GERMANY
7.4.2.3 UNITED KINGDOM
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 CHINA
7.4.3.2 JAPAN
7.4.3.3 INDIA
7.4.3.4 AUSTRALIA & NEW ZEALAND
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF ASIA-PACIFIC
7.4.4 MIDDLE EAST & AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF THE MIDDLE EAST & AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 ABBOTT NUTRITION
9.2 NESTLE HEALTH SCIENCE
9.3 BAXTER HEALTHCARE
9.4 B. BRAUN MELSUNGEN AG
9.5 NUTRICIA
9.6 MEAD JOHNSON
9.7 PERRIGO COMPANY PLC
9.8 FRESENIUS KABI
10. FUTURE OF THE MARKET

ABBOTT NUTRITION
NESTLE HEALTH SCIENCE
BAXTER HEALTHCARE
B. BRAUN MELSUNGEN AG
NUTRICIA
MEAD JOHNSON
PERRIGO COMPANY PLC
FRESENIUS KABI